Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

Impact of brain tumors and radiotherapy on the presence of gadolinium in the brain after repeated administration of gadolinium-based contrast agents: an experimental study in rats.

Jost G, Frenzel T, Boyken J, Pietsch H.

Neuroradiology. 2019 Jul 11. doi: 10.1007/s00234-019-02256-3. [Epub ahead of print]

PMID:
31297571
2.

Gadolinium Presence in the Brain After Administration of the Liver-Specific Gadolinium-Based Contrast Agent Gadoxetate: A Systematic Comparison to Multipurpose Agents in Rats.

Jost G, Frenzel T, Boyken J, Schoeckel L, Pietsch H.

Invest Radiol. 2019 Aug;54(8):468-474. doi: 10.1097/RLI.0000000000000559.

PMID:
30932931
3.

Long-term Excretion of Gadolinium-based Contrast Agents: Linear versus Macrocyclic Agents in an Experimental Rat Model.

Jost G, Frenzel T, Boyken J, Lohrke J, Nischwitz V, Pietsch H.

Radiology. 2019 Feb;290(2):340-348. doi: 10.1148/radiol.2018180135. Epub 2018 Nov 13.

PMID:
30422091
4.

Impact of Treatment With Chelating Agents Depends on the Stability of Administered GBCAs: A Comparative Study in Rats.

Boyken J, Frenzel T, Lohrke J, Jost G, Schütz G, Pietsch H.

Invest Radiol. 2019 Feb;54(2):76-82. doi: 10.1097/RLI.0000000000000522.

5.

Gadolinium Deposition in the Brain after Contrast-enhanced MRI: Are the Data Valid?

Boyken J, Niendorf T, Flemming B, Seeliger E.

Radiology. 2018 Aug;288(2):630-632. doi: 10.1148/radiol.2018171762. Epub 2018 Jun 19. No abstract available.

PMID:
29916783
6.

Methodological Aspects for Preclinical Evaluation of Gadolinium Presence in Brain Tissue: Critical Appraisal and Suggestions for Harmonization-A Joint Initiative.

Robert P, Frenzel T, Factor C, Jost G, Rasschaert M, Schuetz G, Fretellier N, Boyken J, Idée JM, Pietsch H.

Invest Radiol. 2018 Sep;53(9):499-517. doi: 10.1097/RLI.0000000000000467. Review.

8.

Dynamic weight bearing as a non-reflexive method for the measurement of abdominal pain in mice.

Laux-Biehlmann A, Boyken J, Dahllöf H, Schmidt N, Zollner TM, Nagel J.

Eur J Pain. 2016 May;20(5):742-52. doi: 10.1002/ejp.800. Epub 2015 Dec 18.

PMID:
26684879
9.

The GTPase Rab26 links synaptic vesicles to the autophagy pathway.

Binotti B, Pavlos NJ, Riedel D, Wenzel D, Vorbrüggen G, Schalk AM, Kühnel K, Boyken J, Erck C, Martens H, Chua JJ, Jahn R.

Elife. 2015 Feb 2;4:e05597. doi: 10.7554/eLife.05597.

10.

Macromolecular assembly of the adaptor SLP-65 at intracellular vesicles in resting B cells.

Engelke M, Pirkuliyeva S, Kühn J, Wong L, Boyken J, Herrmann N, Becker S, Griesinger C, Wienands J.

Sci Signal. 2014 Aug 19;7(339):ra79. doi: 10.1126/scitranslmed.2005104.

PMID:
25140054
11.

Molecular profiling of synaptic vesicle docking sites reveals novel proteins but few differences between glutamatergic and GABAergic synapses.

Boyken J, Grønborg M, Riedel D, Urlaub H, Jahn R, Chua JJ.

Neuron. 2013 Apr 24;78(2):285-97. doi: 10.1016/j.neuron.2013.02.027.

12.

Quantitative analysis of synaptic vesicle Rabs uncovers distinct yet overlapping roles for Rab3a and Rab27b in Ca2+-triggered exocytosis.

Pavlos NJ, Grønborg M, Riedel D, Chua JJ, Boyken J, Kloepper TH, Urlaub H, Rizzoli SO, Jahn R.

J Neurosci. 2010 Oct 6;30(40):13441-53. doi: 10.1523/JNEUROSCI.0907-10.2010.

13.

The architecture of an excitatory synapse.

Chua JJ, Kindler S, Boyken J, Jahn R.

J Cell Sci. 2010 Mar 15;123(Pt 6):819-23. doi: 10.1242/jcs.052696. Review. No abstract available.

14.

Biophysical characterization of the interaction between hepatic glucokinase and its regulatory protein: impact of physiological and pharmacological effectors.

Anderka O, Boyken J, Aschenbach U, Batzer A, Boscheinen O, Schmoll D.

J Biol Chem. 2008 Nov 14;283(46):31333-40. doi: 10.1074/jbc.M805434200. Epub 2008 Sep 22.

Supplemental Content

Loading ...
Support Center